<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Al-Khersan H</submitter><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>Research to Prevent Blindness</funding><pagination>292-300</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8058287</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>224</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>We compared the ability of ophthalmologists to identify neovascularization (NV) in patients with proliferative diabetic retinopathy using swept-source optical coherence tomography angiography (SS-OCTA) and fluorescein angiography (FA).&lt;h4>Design&lt;/h4>Retrospective study comparing diagnostic instruments.&lt;h4>Methods&lt;/h4>Eyes with proliferative diabetic retinopathy or severe nonproliferative diabetic retinopathy and a high suspicion of NV based on clinical examination were imaged using SS-OCTA and FA at the same visit. Two separate grading sets consisting of scrambled, anonymized SS-OCTA and FA images were created. The ground truth for presence of NV was established by consensus of 2 graders with OCTA experience who did not participate in the subsequent assessment of NV in this</pubmed_abstract><journal>American journal of ophthalmology</journal><pubmed_title>Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein Angiography.</pubmed_title><pmcid>PMC8058287</pmcid><funding_grant_id>P30 EY014801</funding_grant_id><pubmed_authors>Hussain RM</pubmed_authors><pubmed_authors>Russell SR</pubmed_authors><pubmed_authors>Rosenfeld PJ</pubmed_authors><pubmed_authors>Patel NA</pubmed_authors><pubmed_authors>Hariprasad SM</pubmed_authors><pubmed_authors>Russell JF</pubmed_authors><pubmed_authors>Hinkle JW</pubmed_authors><pubmed_authors>Haddock LJ</pubmed_authors><pubmed_authors>Lazzarini TA</pubmed_authors><pubmed_authors>Gregori G</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Fowler BJ</pubmed_authors><pubmed_authors>Scott NL</pubmed_authors><pubmed_authors>Feuer W</pubmed_authors><pubmed_authors>Yannuzzi NA</pubmed_authors><pubmed_authors>Sridhar J</pubmed_authors><pubmed_authors>Al-Khersan H</pubmed_authors><pubmed_authors>Barikian A</pubmed_authors><pubmed_authors>Smiddy WE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparison Between Graders in Detection of Diabetic Neovascularization With Swept Source Optical Coherence Tomography Angiography and Fluorescein Angiography.</name><description>&lt;h4>Purpose&lt;/h4>We compared the ability of ophthalmologists to identify neovascularization (NV) in patients with proliferative diabetic retinopathy using swept-source optical coherence tomography angiography (SS-OCTA) and fluorescein angiography (FA).&lt;h4>Design&lt;/h4>Retrospective study comparing diagnostic instruments.&lt;h4>Methods&lt;/h4>Eyes with proliferative diabetic retinopathy or severe nonproliferative diabetic retinopathy and a high suspicion of NV based on clinical examination were imaged using SS-OCTA and FA at the same visit. Two separate grading sets consisting of scrambled, anonymized SS-OCTA and FA images were created. The ground truth for presence of NV was established by consensus of 2 graders with OCTA experience who did not participate in the subsequent assessment of NV in this</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-04-29T11:30:00.734Z</modification><creation>2025-04-06T19:55:08.365Z</creation></dates><accession>S-EPMC8058287</accession><cross_references><pubmed>33309812</pubmed><doi>10.1016/j.ajo.2020.11.020</doi></cross_references></HashMap>